Full-Time
Senior Manager
Clinical Trials Management
Posted on 11/23/2025
ConvaTec Group
5,001-10,000 employees
Develops medical devices for chronic care
No salary listed
Lexington, MA, USA
Hybrid
Hybrid role; Massachusetts residents must work 2 days on-site.
UK Citizenship Required
 Medical, Clinical & Veterinary (1) |
|---|
- Bachelor degree in a scientific or health related discipline.
- Advanced scientific or business degree or equivalent experience desirable.
- Minimum of 8 to 10 years of clinical trial management experience in conducting and leading global medical device clinical trials, preferably with a sponsor company.
- Solid understanding of the device development process, ICH guidelines/GCP and specifically US/EU patient data privacy laws.
- Demonstrated ability to lead teams in a fast-paced matrixed environment, with the ability to manage and prioritize multiple tasks simultaneously.
- Ability to successfully engage and work collaboratively with cross functional team members including regulatory, R&D, project/program management, data management, and medical monitors.
- Daily interaction with clinical study managers, clinical research associates, data management and other members of the cross-functional study team; frequent cross-functional interactions with internal and external personnel (e.g., investigators, CROs, vendors, etc.).
- Assist with the writing and development of SOPs as required to ensure compliance to regulations and local laws, while maintaining clear instructions for procedures and activities to the achievement of company goals.
- Enjoy building relationships with KOLs and site personnel with a willingness to travel to establish and build relationships.
- Experience in vendor selection and overseeing studies being managed by a CRO.
- Reviews site study documents (informed consent template and study tools/worksheets), investigator contracts, and site payments as needed.
- Strong understanding of clinical study budgets, accruals, and forecasting.
- Participates in site initiation, monitoring and close out visits as appropriate.
- Demonstrated ability to solve problems and use clear judgment in relation to regulatory requirements, interactions with external parties, timelines, and complex clinical programs.
- Coaches and provides guidance to clinical staff, will have management responsibilities for clinical trial management staff.
- Independently motivated, detail oriented and good problem-solving ability.
- Excellent communication skills.
- Experience in wound care, ostomy, and / or incontinence is a plus.
- Working closely with Clinical Study Managers (CSMs) and Clinical Research Associates (CRAs), manage all operational aspects from start-up to close-out activities of studies to assure adherence to timelines, budget and milestones while ensuring compliance with applicable SOPs, guidelines, and regulations.
- Working closely with the Global Head of Clinical Operations, develop study level operational strategy and clinical operations plans in support of execution of the Clinical Portfolio.
- Working closely with CSMs, manage invoice and budget tracking for individual studies and provide input into budget forecasting activities.
- Support the selection, oversight, and management of Clinical Research Organizations (CROs) and other vendors for clinical studies that are outsourced to third party vendors (with the exception of data management / data analytics as this service would be managed by Convatec’s Manager, Data Management & Analytics).
- Monitor and assess vendor performance against contractual operational deliverables.
- Drive performance, quality, timelines, and relationships in partnership with the CRO and other vendors.
- Provide oversight of study scope, quality, timelines, and budget with the internal functional leads, CRO and vendors to ensure project objectives remain on track.
- Participate in a site engagement program to build solid professional relationships with key opinion leaders and clinical site staff to support clinical trial enrolment and other activities.
- Responsible for planning and conducting investigator meetings together with the CRO or Convatec meeting event planner.
- Partner with the CRO or lead CRA and CSM to ensure patient enrollment strategies are conducted effectively and on time.
- Participate in proactive data monitoring activities with the lead CRA to ensure quality and completeness of study data.
- Evaluate issues and suggest and implement solutions and mitigation as required.
- Create appropriate risk assessments and mitigation plans, perform regular reviews to continually assess changing circumstances.
- Review and provide clinical operations input into relevant clinical documents such as the protocol, investigator brochure, regulatory documents, clinical study reports and other documents and plans as appropriate.
- May independently manage Convatec clinical studies as needed.
- Advanced scientific or business degree or equivalent experience desirable.
- Experience in wound care, ostomy, and / or incontinence is a plus.
Convatec Group provides medical devices and services for chronic care. It designs, manufactures, and distributes products across wound care, ostomy care, continence care, and infusion care for patients and healthcare providers in nearly 100 countries. Its products aim to prevent infection, protect the skin, and support safer, easier patient care, while helping health systems lower overall costs. A notable example is the compact catheter for women, which combines discreet use with reliable protection. The company employs about 10,000 people and operates under a commitment to ongoing, reliable care—’forever caring’—to meet evolving patient and system needs. The goal is to improve patient outcomes and reduce the total cost of care through clinically and economically beneficial medical devices and services.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
London, United Kingdom
Founded
1978
Simplify's Take
What believers are saying
- Achieves 6.4% organic growth in 2025 across all segments, infusion care at 12.5%.
- Secures $500M senior notes at 5.3% due 2035, refinancing debt for flexibility.
- Partners LTIMindtree for AI-powered SAP S/4HANA, streamlining global operations.
What critics are saying
- CMS cuts InnovaMatrix price 80% to $127/sq cm, slashing 2026 revenue 2%.
- Novo Holdings sells entire 7.8% stake for £351M, exiting strategic investment.
- Eakin freeseal co-branding erodes proprietary ostomy margins against Hollister, Coloplast.
What makes ConvaTec Group unique
- Leads with Hydrofiber technology, selling 1.5 billion Aquacel dressings over 30 years.
- Launches ConvaNiox dressing healing 60% more diabetic foot ulcers three times faster.
- Introduces eakin freeseal, thinnest 1.8mm ostomy seal absorbing four times its weight.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Company News
Convatec and Eakin Healthcare have launched eakin freeseal, a co-branded ostomy seal in the United States as part of Convatec's ESENTA family of accessories. The product is designed to prevent leaks and protect skin around stomas, addressing a significant need as approximately 90% of the 1 million Americans living with a stoma experience leakage. The eakin freeseal range includes two lines: eakin freeseal air, the thinnest seal on the market at 1.8mm depth, and eakin freeseal versa, which absorbs fluid without breaking down. Both products can absorb up to four times their weight in fluid whilst maintaining integrity beneath the skin barrier. The launch expands the partnership between Convatec, a global medical products company with over $2 billion in 2025 revenues, and Eakin Healthcare, a Northern Ireland-based ostomy solutions specialist.
Convatec and Eakin Healthcare have launched eakin freeseal, a co-branded ostomy seal designed to prevent leaks and protect skin around stomas, as part of Convatec's ESENTA family of accessories in the United States. The product range includes two lines: eakin freeseal air, the thinnest seal on the market at 1.8mm depth, designed for convex pouches; and eakin freeseal versa, which absorbs fluid without breaking down. The seals can absorb up to four times their weight in fluid whilst maintaining integrity beneath the skin barrier. With approximately 1 million people living with stomas in the US, about 90% experience leakage at some point. The new seals address this critical issue in one of the largest and fastest-growing product categories in ostomy care.
Convatec introduces co-branded eakin freeseal(R) ostomy seal in north america, expanding the ESENTA(TM) family of accessories. * 21 hrs ago Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, and Eakin Healthcare, a specialist provider of ostomy solutions, today announced the launch of eakin freeseal(R), the thinnest ostomy seal used to help prevent leaks and protect the skin around a stoma. This new co-branded seal is part of the ESENTA(TM) family of accessories, available in the United States. Ostomy seals are designed to create a protective layer around the stoma to prevent leakage. Recurrent leakage can lead to skin breakdown and irritation, leading to longer term issues, both physically and emotionally for patients. With approximately 1 million people living with a stoma in the United States, about 90% experience leakage at some point in their journey[3]. The use of ostomy seals can reduce or eliminate leakage, leading to a better quality of life for those living with an ostomy. The eakin freeseal(R) range includes two product lines, eakin freeseal(R) air, and eakin freeseal(R) versa, providing healthcare professionals with versatile options that combine discretion, comfort and high performance. While Convatec currently addresses the patient's needs with the eakin Cohesive(R) seal, eakin freeseal(R) provides healthcare professionals with a wider range of options to meet their clinical needs. The thinner offering, eakin freeseal(R) air has a depth starting at 1.8mm, making it the thinnest seal on the market and is designed to be paired with convex pouches. eakin freeseal(R) versa is slightly thicker and designed to absorb fluid at the best rate in the market without breaking down, leading to easier removal for the end user. The thinness of this new ostomy seal, together with its composition and design, allows it to absorb up to four times its weight in fluid without breaking down underneath the skin barrier[1]. This high performance, combined with eakin(R) seals' best-in-market moldability[2], makes eakin freeseal(R) a relatable solution to any person living with a stoma immediately post-surgery. Ostomy seals and barriers designed to prevent leakage and skin irritation is one of the largest product categories in the United States and continues to grow at a consistent rate. Dan Yrigoyen, Vice President, US Ostomy Care at Convatec, said: "We are pleased to add eakin freeseal(R) to our ESENTA(TM) family of skin-friendly accessories, expanding the range of trusted options available to clinicians and patients, and supporting easier, more confident everyday care. with our forever caring promise. This marks a new chapter in the longstanding partnership between Convatec and Eakin Healthcare. Together we continue to advance ostomy care in line with our forever caring promise." This co-branded product reflects Convatec and Eakin Healthcare's ongoing commitment to patients and healthcare professionals to provide choice - working together to provide a better ostomy experience so patients can live the life they want. Integrating eakin(R) seals into the ESENTA(TM) range reinforces the importance of using a reliable ostomy seal as part of the customers skincare routine. About Eakin Healthcare Eakin Healthcare is a medical device manufacturer with headquarters based in Comber, Northern Ireland. Founded in 1973, pharmacist Tom Eakin saw a need to support individuals living with a stoma with better ostomy products to improve comfort, confidence, and quality of life. The company continues to build on its heritage of patient-focused innovation, combining clinical insight with advanced manufacturing to deliver reliable medical devices used worldwide. With a global presence and a strong focus on quality, the company works to enhance the lives of people managing complex healthcare needs. To learn more please visit http://www.eakinostomy.com About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com References: * Mc Groggan G, Haughey S and McDowell K (2018) An absorbent, enzyme-inhibiting seal reduces peristomal skin complications. Gastrointestinal Nursing 16:1 42-4. * T.G. Eakin Laboratory Testing Summary report, ostomy seals 2023 (Data on file) EA-005683-ST * Eakin Healthcare Stoma Census 2023 n=1992. Data on file.
Convatec introduces co-branded eakin freeseal(R) ostomy seal in north america, expanding the ESENTA(TM) family of accessories. * 1 hr ago Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, and Eakin Healthcare, a specialist provider of ostomy solutions, today announced the launch of eakin freeseal(R), the thinnest ostomy seal used to help prevent leaks and protect the skin around a stoma. This new co-branded seal is part of the ESENTA(TM) family of accessories, available in the United States. Ostomy seals are designed to create a protective layer around the stoma to prevent leakage. Recurrent leakage can lead to skin breakdown and irritation, leading to longer term issues, both physically and emotionally for patients. With approximately 1 million people living with a stoma in the United States, about 90% experience leakage at some point in their journey[3]. The use of ostomy seals can reduce or eliminate leakage, leading to a better quality of life for those living with an ostomy. The eakin freeseal(R) range includes two product lines, eakin freeseal(R) air, and eakin freeseal(R) versa, providing healthcare professionals with versatile options that combine discretion, comfort and high performance. While Convatec currently addresses the patient's needs with the eakin Cohesive(R) seal, eakin freeseal(R) provides healthcare professionals with a wider range of options to meet their clinical needs. The thinner offering, eakin freeseal(R) air has a depth starting at 1.8mm, making it the thinnest seal on the market and is designed to be paired with convex pouches. eakin freeseal(R) versa is slightly thicker and designed to absorb fluid at the best rate in the market without breaking down, leading to easier removal for the end user. The thinness of this new ostomy seal, together with its composition and design, allows it to absorb up to four times its weight in fluid without breaking down underneath the skin barrier[1]. This high performance, combined with eakin(R) seals' best-in-market moldability[2], makes eakin freeseal(R) a relatable solution to any person living with a stoma immediately post-surgery. Ostomy seals and barriers designed to prevent leakage and skin irritation is one of the largest product categories in the United States and continues to grow at a consistent rate. Dan Yrigoyen, Vice President, US Ostomy Care at Convatec, said: "We are pleased to add eakin freeseal(R) to our ESENTA(TM) family of skin-friendly accessories, expanding the range of trusted options available to clinicians and patients, and supporting easier, more confident everyday care. with our forever caring promise. This marks a new chapter in the longstanding partnership between Convatec and Eakin Healthcare. Together we continue to advance ostomy care in line with our forever caring promise." This co-branded product reflects Convatec and Eakin Healthcare's ongoing commitment to patients and healthcare professionals to provide choice - working together to provide a better ostomy experience so patients can live the life they want. Integrating eakin(R) seals into the ESENTA(TM) range reinforces the importance of using a reliable ostomy seal as part of the customers skincare routine. About Eakin Healthcare Eakin Healthcare is a medical device manufacturer with headquarters based in Comber, Northern Ireland. Founded in 1973, pharmacist Tom Eakin saw a need to support individuals living with a stoma with better ostomy products to improve comfort, confidence, and quality of life. The company continues to build on its heritage of patient-focused innovation, combining clinical insight with advanced manufacturing to deliver reliable medical devices used worldwide. With a global presence and a strong focus on quality, the company works to enhance the lives of people managing complex healthcare needs. To learn more please visit http://www.eakinostomy.com About Convatec Pioneering trusted medical solutions to improve the lives Wpgxfox28 touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, Wpgxfox28 provide products and services in around 90 countries, united by a promise to be forever caring. Its solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com References: * Mc Groggan G, Haughey S and McDowell K (2018) An absorbent, enzyme-inhibiting seal reduces peristomal skin complications. Gastrointestinal Nursing 16:1 42-4. * T.G. Eakin Laboratory Testing Summary report, ostomy seals 2023 (Data on file) EA-005683-ST * Eakin Healthcare Stoma Census 2023 n=1992. Data on file.
ConvaTec Group reported its fifth consecutive year of organic revenue growth in 2025, with operating margin expanding 110 basis points to 22.3% and earnings per share rising 16%. The medical devices company delivered organic growth of 6.4% excluding InnovaMatrix, with strong performance across all four business segments led by infusion care at 12.5%. The company faces a significant headwind from its InnovaMatrix product after US Medicare reduced pricing by approximately 80% to $127 per square centimetre, resulting in a £72 million non-cash impairment and an expected 2% revenue headwind in 2026. Management guided to roughly $20 million in InnovaMatrix sales for 2026. ConvaTec reiterated 2026 guidance for 5-7% organic growth excluding InnovaMatrix and operating margin of at least 23%, whilst raising its longer-term organic growth target to 6-8% from 2027.